These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3420535)

  • 1. Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylation.
    Kawabuchi M; Boyne AF; Deshpande SS; Cintra WM; Brossi A; Albuquerque EX
    Synapse; 1988; 2(2):139-47. PubMed ID: 3420535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reversible carbamate, (-)physostigmine, reduces the size of synaptic end plate lesions induced by sarin, an irreversible organophosphate.
    Kawabuchi M; Boyne AF; Deshpande SS; Albuquerque EX
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):98-106. PubMed ID: 2916238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
    Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX
    Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning.
    Albuquerque EX; Deshpande SS; Kawabuchi M; Aracava Y; Idriss M; Rickett DL; Boyne AF
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S182-203. PubMed ID: 2868960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
    Harris LW; Anderson DR; Pastelak AM; Vanderpool B
    Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the ultrastructural myopathy induced by anticholinesterase agents at the end plates of rat soleus and extensor muscles.
    Meshul CK; Boyne AF; Deshpande SS; Albuquerque EX
    Exp Neurol; 1985 Jul; 89(1):96-114. PubMed ID: 4007120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physostigmine--an overview as pretreatment drug for organophosphate intoxication.
    Somani SM; Dube SN
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):367-87. PubMed ID: 2676871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of reversible and irreversible cholinesterase inhibitors on the monosynaptic reflex in neonatal rats.
    Das Gupta S; Bass KN; Warnick JE
    Toxicol Appl Pharmacol; 1989 Jun; 99(1):28-36. PubMed ID: 2727998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physostigmine-induced hypothermic response in rats and its relationship with endogenous arginine vasopressin.
    Yang YL; Shen ZL; Zou Q; Tang Y; Huang T
    Life Sci; 2009 Oct; 85(15-16):586-91. PubMed ID: 19723529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pretreatment of carbamates on dynamic pulmonary mechanics in rats exposed to sarin aerosols.
    Husain K; Kumar P; Vijayaraghavan R; Singh R; Das Gupta S
    Indian J Physiol Pharmacol; 1993 Jul; 37(3):249-51. PubMed ID: 8276509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physostigmine modulation of acetylcholine currents in COS cells transfected with mouse muscle nicotinic receptor.
    Svobodová L; Krůsek J; Hendrych T; Vyskocil F
    Neurosci Lett; 2006 Jun; 401(1-2):20-4. PubMed ID: 16530961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from quinidine or physostigmine against in vitro inhibition by sarin of acetylcholinesterase activity.
    Singh AK; Zeleznikar RJ; Drewes LR
    Life Sci; 1986 Jan; 38(2):165-72. PubMed ID: 3945161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of neurotoxicity of and lack of tolerance to the anticholinesterases soman and sarin in the rat.
    Fernando JC; Lim DK; Hoskins B; Ho IK
    Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):415-30. PubMed ID: 4023423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
    Solana RP; Gennings C; Carter WH; Anderson D; Lennox WJ; Carchman RA; Harris LW
    Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular dysfunction induced by acetylcholinesterase inhibition.
    Wecker L; Laskowski B; Dettbarn WD
    Fed Proc; 1978 Dec; 37(14):2818-22. PubMed ID: 214351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents.
    Shih TM; Kan RK; McDonough JH
    Chem Biol Interact; 2005 Dec; 157-158():293-303. PubMed ID: 16256093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
    Shih TM; Skovira JW; O'Donnell JC; McDonough JH
    Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient and reversible nephrotoxicity of sarin in rats.
    Bloch-Shilderman E; Levy A
    J Appl Toxicol; 2007; 27(2):189-94. PubMed ID: 17154277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.